Epidemiology and prevention of venous thromboembolism

PL Lutsey, NA Zakai - Nature Reviews Cardiology, 2023 - nature.com
Venous thromboembolism, that consists of the interrelated conditions deep-vein thrombosis
and pulmonary embolism, is an under-appreciated vascular disease. In Western regions …

How low to go with glucose, cholesterol, and blood pressure in primary prevention of CVD

KN Hong, V Fuster, RS Rosenson, C Rosendorff… - Journal of the American …, 2017 - jacc.org
Diabetes, hyperlipidemia, and hypertension are modifiable risk factors that predict
cardiovascular disease events. The effect of these risk factors on incident cardiovascular …

The global burden of cardiovascular diseases and risk: a compass for future health

M Vaduganathan, GA Mensah, JV Turco… - Journal of the American …, 2022 - jacc.org
PUBLISHED BY ELSEVIER levels stratified by age and sex. Estimates of several summary
epidemiological measures are produced, including composite measures such as …

Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia

DL Bhatt, PG Steg, M Miller, EA Brinton… - … England Journal of …, 2019 - Mass Medical Soc
Background Patients with elevated triglyceride levels are at increased risk for ischemic
events. Icosapent ethyl, a highly purified eicosapentaenoic acid ethyl ester, lowers …

Cardiovascular risk and statin eligibility of young adults after an MI: partners YOUNG-MI registry

A Singh, BL Collins, A Gupta, A Fatima, A Qamar… - Journal of the American …, 2018 - jacc.org
Background: Despite significant progress in primary prevention, the rate of MI has not
declined in young adults. Objectives: The purpose of this study was to evaluate statin …

Interaction of heart failure and stroke: A clinical consensus statement of the ESC Council on Stroke, the Heart Failure Association (HFA) and the ESC Working Group …

W Doehner, M Böhm, G Boriani… - European Journal of …, 2023 - Wiley Online Library
Heart failure (HF) is a major disease in our society that often presents with multiple
comorbidities with mutual interaction and aggravation. The comorbidity of HF and stroke is a …

Benefits of icosapent ethyl across the range of kidney function in patients with established cardiovascular disease or diabetes: REDUCE-IT RENAL

A Majithia, DL Bhatt, AN Friedman, M Miller, PG Steg… - Circulation, 2021 - ahajournals.org
Background: Chronic kidney disease is associated with adverse outcomes among patients
with established cardiovascular disease (CVD) or diabetes. Commonly used medications to …

A comprehensive lifestyle peer group–based intervention on cardiovascular risk factors: the randomized controlled fifty-fifty program

E Gómez-Pardo, JM Fernández-Alvira… - Journal of the American …, 2016 - jacc.org
Background: Cardiovascular diseases stem from modifiable risk factors. Peer support is a
proven strategy for many chronic illnesses. Randomized trials assessing the efficacy of this …

[HTML][HTML] Primary prevention of atherosclerosis: time to take a selfie?

V Nambi, DL Bhatt - Journal of the American College of Cardiology, 2017 - jacc.org
“Normal” blood pressure,“normal” cholesterol, and “no” diabetes are terms that patients are
happy to hear at the end of their clinical visit because they consider these terms to be …

Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same

M Manku, I Osterloh, P Wicker, R Braeckman… - US Patent …, 2021 - Google Patents
(51) Int. Cl. A61K 31/00(2006.01) A61K 9/00(2006.01) A61K 45/00(2006.01) A61K
31/202(2006.01) A61K 45/06(2006.01) A61K 31/222(2006.01) A61K 31/232(2006.01) A61K …